BABASSU: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews

Overview

Babassu is a type of palm tree that grows in Brazil. People use parts of the fruit and the oil found in the kernels to make medicine.

People use babassu for conditions such as cancer, infections of the kidney, bladder, or urethra (urinary tract infections or UTIs), wounds, and many others, but there is no good scientific evidence to support these uses.

How does it work ?

Babassu contains chemicals that can reduce swelling (inflammation) and slow blood clotting.

Uses & Effectiveness

Insufficient Evidence for

Cancer.
Constipation.
Swelling (inflammation) of the stomach (gastritis).
Obesity.
Pain.
Rheumatoid arthritis (RA).
Infections of the kidney, bladder, or urethra (urinary tract infections or UTIs).
Poor circulation that can lead to varicose veins and other conditions (venous insufficiency).
Wound healing.
Other conditions.

More evidence is needed to rate babassu for these uses.

Side Effects

When taken by mouth: There isn't enough reliable information to know if babassu is safe or what the side effects might be.

When applied to the skin: There isn't enough reliable information to know if babassu is safe or what the side effects might be.

Special Precautions and Warnings

Pregnancy and breast-feeding: There isn't enough reliable information to know if babassu is safe to use when pregnant or breast-feeding. Stay on the safe side and avoid use.

Bleeding disorders: Babassu might slow blood clotting. In theory, babassu might increase the risk of bruising or bleeding in some people with bleeding disorders.

Surgery: Babassu might slow blood clotting. There is a concern that it might cause extra bleeding during and after surgery. Stop taking babassu at least 2 weeks before surgery.

Thyroid problems such as hypothyroidism (too little thyroid hormone) or goiter: Babassu might decrease thyroid function. This might make certain conditions, such as hypothyroidism or goiter, worse.

Interactions

Moderate Interaction

Be cautious with this combination

Medications for an overactive thyroid (Antithyroid drugs) interacts with BABASSU
Babassu might decrease thyroid function. Taking babassu along with medications for an overactive thyroid might decrease thyroid function too much. Don't take babassu if you are taking medications for an overactive thyroid.

Some of these medications include methimazole (Tapazole), potassium iodide (Thyro-Block), and others.
Medications that slow blood clotting (Anticoagulant / Antiplatelet drugs) interacts with BABASSU
Babassu might slow blood clotting. Taking babassu along with medications that also slow blood clotting might increase the chances of bruising and bleeding.

Some medications that slow blood clotting include aspirin, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, others), ibuprofen (Advil, Motrin, others), naproxen (Anaprox, Naprosyn, others), dalteparin (Fragmin), enoxaparin (Lovenox), heparin, warfarin (Coumadin), and others.

Dosing

The appropriate dose of babassu depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for babassu. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.

View References

REFERENCES:

Amorim, E., Matias, J. E., Coelho, J. C., Campos, A. C., Stahlke, H. J., Jr., Timi, J. R., Rocha, L. C., Moreira, A. T., Rispoli, D. Z., and Ferreira, L. M. [Topic use of aqueous extract of Orbignya phalerata (babassu) in rats: analysis of its healing effect]. Acta Cir Bras 2006;21 Suppl 2:67-76. View abstract.

Azevedo, A. P., Farias, J. C., Costa, G. C., Ferreira, S. C., Aragao-Filho, W. C., Sousa, P. R., Pinheiro, M. T., Maciel, M. C., Silva, L. A., Lopes, A. S., Barroqueiro, E. S., Borges, M. O., Guerra, R. N., and Nascimento, F. R. Anti-thrombotic effect of chronic oral treatment with Orbignya phalerata Mart. J Ethnopharmacol 2007;111(1):155-159. View abstract.

Baldez, R. N., Malafaia, O., Czeczko, N. G., Martins, N. L., Ferreira, L. M., Ribas, C. A., Salles, Junior G., Del Claro, R. P., Santos Lde, O., Graca Neto, L., and Araujo, L. R. [Healing of colonic anastomosis with the use of extract aqueous of Orbignya phalerata (Babassu) in rats]. Acta Cir Bras 2006;21 Suppl 2:31-38. View abstract.

Batista, C. P., Torres, O. J., Matias, J. E., Moreira, A. T., Colman, D., Lima, J. H., Macri, M. M., Rauen, R. J., Jr., Ferreira, L. M., and de Freitas, A. C. [Effect of watery extract of Orbignya phalerata (babassu) in the gastric healing in rats: morphological and tensiometric study]. Acta Cir Bras 2006;21 Suppl 3:26-32. View abstract.

Brito Filho, S. B., Matias, J. E., Stahlke Junior, H. J., Torres, O. J., Timi, J. R., Tenorio, S. B., Tambara, E. M., Carstens, A. G., Campos, R. V., and Myamoto, M. [Analysis of healing in the Alba Linea with the use of Orbignya phalerata (babassu) water extract. Controlled study in rats]. Acta Cir Bras 2006;21 Suppl 3:76-88. View abstract.

da Silva, B. P. and Parente, J. P. An anti-inflammatory and immunomodulatory polysaccharide from Orbignya phalerata. Fitoterapia 2001;72(8):887-893. View abstract.

Ferreira Ede, C., Matias, J. E., Campos, A. C., Tambara Filho, R., Rocha, L. C., Timi, J. R., Sado, H. N., Sakamoto, D. G., Tolazzi, A. R., and Soares Filho Mde, P. [Surgical bladder wounds treated with Orbignya phalerata aqueous extract: controlled study in rats]. Acta Cir Bras 2006;21 Suppl 3:33-39. View abstract.

Freire, D. M., Sant'Anna, G. L., Jr., and Alves, T. L. Mathematical modeling of lipase and protease production by Penicillium restrictum in a batch fermenter. Appl Biochem Biotechnol 1999;77-79:845-855. View abstract.

Gaitan, E., Cooksey, R. C., Legan, J., Lindsay, R. H., Ingbar, S. H., and Medeiros-Neto, G. Antithyroid effects in vivo and in vitro of babassu and mandioca: a staple food in goiter areas of Brazil. Eur J Endocrinol 1994;131(2):138-144. View abstract.

Luz, C. and Batagin, I. Potential of oil-based formulations of Beauveria bassiana to control Triatoma infestans. Mycopathologia 2005;160(1):51-62. View abstract.

Marques, S. G., Silva Cde, M., Saldanha, P. C., Rezende, M. A., Vicente, V. A., Queiroz-Telles, F., and Costa, J. M. Isolation of Fonsecaea pedrosoi from the shell of the babassu coconut (Orbignya phalerata Martius) in the Amazon region of Maranhao Brazil. Nippon Ishinkin Gakkai Zasshi 2006;47(4):305-311. View abstract.

Martins, N. L., Malafaia, O., Ribas-Filho, J. M., Heibel, M., Baldez, R. N., Vasconcelos, P. R., Moreira, H., Mazza, M., Nassif, P. A., and Wallbach, T. Z. [Healing process in cutaneous surgical wounds in rats under the influence of Orbignya phalerata aqueous extract]. Acta Cir Bras 2006;21 Suppl 3:66-75. View abstract.

Nascimento, F. R., Barroqueiro, E. S., Azevedo, A. P., Lopes, A. S., Ferreira, S. C., Silva, L. A., Maciel, M. C., Rodriguez, D., and Guerra, R. N. Macrophage activation induced by Orbignya phalerata Mart. J Ethnopharmacol 2006;103(1):53-58. View abstract.

Oliveira, F. C., Freire, D. M., and Castilho, L. R. Production of poly(3-hydroxybutyrate) by solid-state fermentation with Ralstonia eutropha. Biotechnol Lett 2004;26(24):1851-1855. View abstract.

Palma, M. B., Pinto, A. L., Gombert, A. K., Seitz, K. H., Kivatinitz, S. C., Castilho, L. R., and Freire, D. M. Lipase production by Penicillium restrictum using solid waste of industrial babassu oil production as substrate. Appl Biochem Biotechnol 2000;84-86:1137-1145. View abstract.

Sarubbo, L. A., Porto, A. L., and Campos-Takaki, G. M. The use of babassu oil as substrate to produce bioemulsifiers by Candida lipolytica. Can J Microbiol 1999;45(5):423-426. View abstract.

Silva, C. M., da Rocha, R. M., Moreno, J. S., Branco, M. R., Silva, R. R., Marques, S. G., and Costa, J. M. [The coconut babacu (Orbignya phalerata martins) as a probable risk of human infection by the agent of chromoblastomycosis in the State of Maranhao, Brazil]. Rev Soc Bras Med Trop 1995;28(1):49-52. View abstract.

Anderson LL, Doohan PT, Oldfield L, et al. Citalopram and Cannabidiol: In Vitro and In Vivo Evidence of Pharmacokinetic Interactions Relevant to the Treatment of Anxiety Disorders in Young People. J Clin Psychopharmacol. 2021. View abstract.

Appiah-Kusi E, Petros N, Wilson R, et al. Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis. Psychopharmacology (Berl). 2020 Jan 8. View abstract.

Arkell TR, Lintzeris N, Kevin RC, et al. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition. Psychopharmacology (Berl). 2019;236(9):2713-2724. View abstract.

Arkell TR, Vinckenbosch F, Kevin RC, Theunissen EL, McGregor IS, Ramaekers JG. Effect of Cannabidiol and ?9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial. JAMA. 2020;324(21):2177-2186. View abstract.

Arout CA, Haney M, Herrmann ES, Bedi G, Cooper ZD. The dose-dependent analgesic effects, abuse liability, safety and tolerability of oral cannabidiol in healthy humans. Br J Clin Pharmacol. 2021. View abstract.

Atieh J, Maselli D, Breen-Lyles M, et al. Cannabidiol for functional dyspepsia with normal gastric emptying: A randomized controlled trial. Am J Gastroenterol 2022;117(8):1296-1304. View abstract.

Aviello G, Romano B, Borrelli F, et al. Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer. J Mol Med (Berl) 2012;90(8):925-34. View abstract.

Bansal S, Zamarripa CA, Spindle TR, et al. Evaluation of Cytochrome P450-Mediated Cannabinoid-Drug Interactions in Healthy Adult Participants. Clin Pharmacol Ther 2023. View abstract.

Baranowska-Kuczko M, Kozlowska H, Kloza M, et al. Vasoprotective Endothelial Effects of Chronic Cannabidiol Treatment and Its Influence on the Endocannabinoid System in Rats with Primary and Secondary Hypertension. Pharmaceuticals (Basel) 2021;14(11):1120. View abstract.

Bass J, Linz DR. A Case of Toxicity from Cannabidiol Gummy Ingestion. Cureus. 2020;12(4):e7688. View abstract.

Bebee B, Taylor DM, Bourke E, et al. The CANBACK trial: a randomised, controlled clinical trial of oral cannabidiol for people presenting to the emergency department with acute low back pain. Med J Aust. 2021;214(8):370-375. View abstract.

Bell AD, MacCallum C, Margolese S, et al. Clinical Practice Guidelines for cannabis and cannabinoid-based medicines in the management of chronic pain and co-occurring conditions. Cannabis Cannabinoid Res. 2023. View abstract.

Ben-Menachem E, Gunning B, Arenas Cabrera CM, et al. A Phase II Randomized Trial to Explore the Potential for Pharmacokinetic Drug-Drug Interactions with Stiripentol or Valproate when Combined with Cannabidiol in Patients with Epilepsy. CNS Drugs. 2020;34(6):661-672. View abstract.

Bergamaschi MM, Queiroz RH, Chagas MH, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology 2011;36(6):1219-26. View abstract.

Berger BA, Stolz U, Colvin J, Otten EJ. Epidemiology of cannabidiol related cases reported in the National Poison Data System - 2019-2020. Am J Emerg Med. 2021;48:218-223. View abstract.

Berger M, Li E, Rice S, et al. Cannabidiol for treatment-resistant anxiety disorders in young people: An open-label trial. J Clin Psychiatry 2022;83(5):21m14130. View abstract.

Bergeria CL, Spindle TR, Cone EJ, et al. Pharmacokinetic Profile of ?9-tetrahydrocannabinol, Cannabidiol and Metabolites in Blood following Vaporization and Oral Ingestion of Cannabidiol Products. J Anal Toxicol 2022. View abstract.

Amorim E, Saad Junior R, Salgado Filho N, et al. The effects of aqueous extract of babassu (Orbignya phalerata) on the pleura and lung parenchyma in rats. Acta Cir Bras 2016;31(4):243-9. doi: 10.1590/S0102-865020160040000004. View abstract.

da Silva, B. P. and Parente, J. P. An anti-inflammatory and immunomodulatory polysaccharide from Orbignya phalerata. Fitoterapia 2001;72(8):887-893. View abstract.

Santos AR, Coelho KL, Coelho CA. Effects of low fat and babassu fat diets on nutritional status in obstructive cholestasis in young rats. Acta Cir Bras 2008;23(1):4-10. View abstract.

Santos JAA, da Silva JW, Dos Santos SM, et al. In Vitro and In Vivo Wound Healing and Anti-Inflammatory Activities of Babassu Oil (Attalea speciosa Mart. Ex Spreng., Arecaceae). Evid Based Complement Alternat Med 2020;2020:8858291. View abstract.

Silva AP, Cerqueira GS, Nunes LC, de Freitas RM. Effects of an aqueous extract of Orbignya phalerata Mart on locomotor activity and motor coordination in mice and as antioxidant in vitro. Pharmazie 2012;67(3):260-3. View abstract.

Soares MCR, Silva MCP, Almeida-Junior FADS, Nascimento JR, Nascimento FRF, Guerra RNM. Effect of Babassu Mesocarp As a Food Supplement During Resistance Training. J Med Food 2021;24(4):411-421. View abstract.

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2024 by Therapeutic Research Center, LLC. All Rights Reserved.